Recruiting Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults NCT06919926 Conditions Brain Diseases, Central Nervous System Diseases, Dementia, +4 more Locations Johns Hopkins University School of Medicine — Baltimore, Maryland, United States View Trial Details
